US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 3.370
- -0.630-15.75%
Close Oct 31 16:00 ET
- 3.550
- +0.180+5.34%
Post 19:57 ET
896.74MMarket Cap-2956P/E (TTM)
4.000High3.330Low7.00MVolume4.000Open4.000Pre Close25.12MTurnover5.32%Turnover RatioLossP/E (Static)266.09MShares7.45052wk High1.70P/B443.42MFloat Cap3.06052wk Low--Dividend TTM131.58MShs Float53.240Historical High--Div YieldTTM16.75%Amplitude1.600Historical Low3.589Avg Price1Lot Size
About Autolus Therapeutics Company
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Company Profile
SymbolAUTL
Company NameAutolus Therapeutics
Listing DateJun 22, 2018
Issue Price17.00
Founded2018
CEODr. Christian Itin, PhD.
MarketNASDAQ
Employees471
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Mediaworks,191 Wood Lane,White City
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW12 7FP
Phone44-20-3829-6230
Websitehttp://www.autolus.com
Company Executives
- Name
- Position
- Salary
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 1.92M
- Alexander Swan
- Senior Vice President, Chief Human Resources Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Robert F. Dolski
- Senior Vice President, Chief Financial Officer
- --
- Martin Pule
- Senior Vice President and Chief Scientific Officer
- --
- Dr. Edgar Braendle
- Senior Vice President and Chief Development Officer
- --
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Michael W. Bonney
- Chairman of the Board
- --
- Robert W. Azelby
- Director
- --
- Dr. Elisabeth Leiderman, M.D.
- Director
- 12.73K
- Dr. Ravi Rao, M.D.
- Director
- --
- Dr. Martin Murphy, PhD
- Independent Director
- 158.28K
- Linda C. Bain
- Independent Director
- 169.52K
- Cynthia M. Butitta
- Independent Director
- 164.65K
- John E. Berriman
- Independent Director
- 163.15K
- Dr. Joseph Anderson, PhD.
- Independent Director
- 195.65K
- William D. Young
- Independent Director
- 175.82K
- Dr. Robert Iannone, M.D.
- Independent Director
- 134.86K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data